Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05628012 · ClinicalTrials.gov registry record · NA
Circadian Time Restricted Eating
A NA study of Weight Loss and Cardiovascular Health, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05628012: Recruiting NA study of Weight Loss and Cardiovascular Health, sponsored by Oregon Health and Science University.
NCT05628012 is a NA study of Weight Loss and Cardiovascular Health that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 10 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05628012, a NA study of Weight Loss and Cardiovascular Health, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn more about how the time in which participants consume their meals relative to their personalized circadian rhythm influences their overall cardiometabolic health and weight. The investigators are hoping to discover if a circadian-based time restricted eating intervention will improve cardiometabolic health and decrease weight. The protocol is a 46 day prospective cohort study that includes both field and in-laboratory data collection in overweight and obese individuals.
Conditions Studied
Interventions
- BEHAVIORAL Circadian Based Time Restricted Eating
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What NCT05628012 shows while recruiting
NCT05628012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which Circadian Based Time Restricted Eating is the first listed.
NCT05628012 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05628012 about?
NCT05628012 is a clinical study titled "Circadian Time Restricted Eating". The goal of this study is to learn more about how the time in which participants consume their meals relative to their personalized circadian rhythm influences their overall cardiometabolic health and weight. The investigators are hoping to discover if a circadian-based time restricted eating interv...
What is the current status of trial NCT05628012?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-04-01. Estimated completion is 2024-12-01.
What conditions does trial NCT05628012 study?
This clinical trial studies the following conditions: Weight Loss, Cardiovascular Health, Circadian Rhythm, Time Restricted Feeding, Cardiometabolic Health.
What interventions are being tested in trial NCT05628012?
The interventions under investigation include: Circadian Based Time Restricted Eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT05628012?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05628012 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05628012's enrollment target sits among peer trials
10 116th of 116 higher than 1 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
-
Dyad Plus Effectiveness/Feasibility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI